Seprafilm(®) adhesion barrier: (2) a review of the clinical literature on intraabdominal use
{{output}}
This study seeks to provide a review of the clinical data published as of July 2011 concerning the postsurgical adhesion barrier, Seprafilm (chemically modified hyaluronic acid and carboxymethylcelulose; Genzyme Corporation, Cambridge, MA). Included articles d... ...
